TELEMS: Feasibility of Remote Patient Visits in MS

NCT04838990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2022-01-21

No results posted yet for this study

Summary

This trials randomizes patients with multiple sclerosis (MS, pwMS) to a remote visit (via phone or videochat) or a regular outpatient visit. Outcomes include satisfaction on the patients' and doctor's side.

Conditions

Interventions

OTHER

EDSS

Neurological Exam - EDSS (Expanded Disability Status Scale)

OTHER

Discussion of symptoms, Patient reported outcome (MSIS)

Patients will be asked about their wellbeing

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Patrick Altmann, MD PhD · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-09-01
Completion
2021-10-01

Countries

  • Austria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04838990 on ClinicalTrials.gov